In Athens, we brought a clear ambition to the stage: make expert-quality vascular ultrasound available in every clinic.
Ultrasound AIssistant took second place at the StartSmart SEE Accelerator 2026 Demo Day, held as part of the MIT Universal AI Summit on June 30. The result marked a milestone in a journey that began with our selection for the accelerator earlier in the year.
Throughout that journey, our central question remained the same: how do we turn specialist vascular expertise into technology that can reach far beyond a single examination room?
Our answer is to bring AI into the examination itself. Ultrasound AIssistant is being developed to guide clinicians in real time, translating specialist scanning knowledge into a workflow that can be used across operators and clinical settings. We are building toward a future where access to expert-quality examinations can expand with the clinics that need them.
The StartSmart SEE program gave us a setting to present that vision, engage with the startup ecosystem, and discuss the path from technology development to a scalable business. Demo Day brought the story onto an international stage, alongside other teams working to turn ambitious ideas into practical products.
At the MIT Universal AI Summit, our CEO, Ljubiša Vulić, presented our approach to scaling vascular expertise. We also demonstrated the software on a tablet, making the connection between the ambition and the examination workflow visible.
For us, the significance of the second-place finish extends beyond the award. It gives partners and investors a concrete milestone to follow as we build the company. It also creates an opportunity to explain the work ahead: continued product development, clinical evaluation, and collaboration with organizations that can help bring the technology into practice.
Our ambition reaches well beyond Athens. We want to make specialist knowledge transferable, examination quality more consistent, and vascular expertise accessible in more places.
That future will be built through engineering, clinical evidence, and the ability to execute. StartSmart SEE was an important stage in the journey. The next is to carry that ambition forward into the product and the business we are building.

